SCHEDULE: FMR LLC Reports 8.1% Stake in 10x Genomics Class A Stock

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing an 8.1% beneficial ownership stake in 10x Genomics, Inc.'s Class A Common Stock as of September 30, 2025.

Summary

• FMR LLC and Abigail P. Johnson collectively beneficially own 9,283,772.62 shares of 10x Genomics, Inc. Class A Common Stock.
• This ownership represents 8.1% of the Class A Common Stock outstanding.
• The reported beneficial ownership includes 892,772 shares of Class B Common Stock, which are convertible into Class A Common Stock on a 1:1 basis.
• These Class B shares represent 8.8579% of the outstanding Class B Common Stock.
• Assuming conversion of all outstanding Class B Common Stock, the reported shares would represent 7.4574% of the outstanding Class A Common Stock.
• FMR LLC holds sole voting power over 9,249,927.00 shares and sole dispositive power over 9,283,772.62 shares.
• Abigail P. Johnson, as a control person of FMR LLC, is deemed to beneficially own the same aggregate amount of shares with sole dispositive power.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of 10x Genomics, Inc.

Sentiment

Score: 5

Explanation: This is a factual regulatory filing reporting beneficial ownership, which is inherently neutral regarding the issuer's performance. However, the continued significant stake by a major institutional investor like FMR LLC can imply a degree of confidence in the company.

Future Outlook

NA

Industry Context

This filing reflects a significant, ongoing institutional investment in 10x Genomics, a company operating in the biotechnology and genomics sector. The continued substantial stake by a major asset manager like FMR LLC can be interpreted as a sign of confidence in the company's long-term prospects within its specialized industry.

Stakeholder Impact

• Shareholders: The continued significant ownership by a major institutional investor like FMR LLC may instill confidence among existing and potential shareholders, signaling a belief in the company's value.

Key Dates

Keywords

10x Genomics, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Class A Common Stock, Schedule 13G, Institutional Investor, Biotechnology, Genomics